Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
Au TH, Willis C, Reblin M, Peters KB, Nghiemphu PL, Taylor JW, Colman H, Cohen AL, Ormond DR, Chakravarti A, Willmarth N, Menon J, Ma J, Bauer H, Watanabe AH, Ulrich CM, Singh P, Marshall A, Korytowsky B, Stenehjem D, Brixner D. Au TH, et al. Among authors: korytowsky b. Support Care Cancer. 2022 Feb;30(2):1377-1378. doi: 10.1007/s00520-021-06691-y. Support Care Cancer. 2022. PMID: 34792647 Free PMC article. No abstract available.
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
Au TH, Willis C, Reblin M, Peters KB, Nghiemphu PL, Taylor JW, Colman H, Cohen AL, Ormond DR, Chakravarti A, Willmarth N, Menon J, Ma J, Bauer H, Watanabe AH, Ulrich CM, Singh P, Marshall A, Korytowsky B, Stenehjem D, Brixner D. Au TH, et al. Among authors: korytowsky b. Support Care Cancer. 2022 Feb;30(2):1365-1375. doi: 10.1007/s00520-021-06514-0. Epub 2021 Sep 11. Support Care Cancer. 2022. PMID: 34510238 Free PMC article.
Tumor mutational burden in lung cancer: a systematic literature review.
Willis C, Fiander M, Tran D, Korytowsky B, Thomas JM, Calderon F, Zyczynski TM, Brixner D, Stenehjem DD. Willis C, et al. Among authors: korytowsky b. Oncotarget. 2019 Nov 12;10(61):6604-6622. doi: 10.18632/oncotarget.27287. eCollection 2019 Nov 12. Oncotarget. 2019. PMID: 31762941 Free PMC article. Review.
A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
Norden AD, Korytowsky B, You M, Kim Le T, Dastani H, Bobiak S, Singh P. Norden AD, et al. Among authors: korytowsky b. J Manag Care Spec Pharm. 2019 Apr;25(4):428-436. doi: 10.18553/jmcp.2019.25.4.428. J Manag Care Spec Pharm. 2019. PMID: 30917077 Free PMC article.
Patients were excluded if they had (a) another primary cancer within 6 months pre-index, (b) secondary brain metastases, or (c) received temozolomide and/or RT pre-index. Baseline characteristics, treatments, HCRU, and costs were reported. ...Norden received consultancy fe …
Patients were excluded if they had (a) another primary cancer within 6 months pre-index, (b) secondary brain metastases, or (c) recei …
34 results